Low-Dose Tramadol-Induced Seizure: A Case Report

ABSTRACT

Tramadol is a weak mu (µ) opioid receptor agonist that acts by inhibiting serotonin and norepinephrine uptake. Tramadol undergoes extensive hepatic metabolism by a number of pathways, including CYP2D6 and CYP3A4, and by conjugation with subsequent renal excretion. The maximum recommended dose is 400 mg/day. One of the most important adverse effects of tramadol is a seizure, which usually occurs at high doses and is often generalized tonic–clonic type and self-limiting. Here, we present a case of a patient with inflammatory low backache who developed seizures while on low-dose oral tramadol. After 1 h of taking the first tablet of tramadol, he developed morbilliform rashes all over the body. One day later, he developed generalized tonic–clonic seizures followed by a loss of consciousness for 5 min. The patient was admitted to the hospital and managed conservatively with injection lorazepam and tramadol was stopped. In general, if applied in overdose, tramadol can only incite seizures in patients already suffering from some sort of disorder related to seizures or if it is administered along with antidepressants, alcohol, etc. But here, only with the use of 37.5 mg oral application, the incidence of seizure happened.

KEYWORDS

• Tramadol
• Seizure
• Low dose
• Rash

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X221107494Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 13, ISSUE 2In Silico Modeling and Docking Analysis of CTX-M-5, Cefotaxime-Hydrolyzing β-Lactamase from Human-Associated Salmonella TyphimuriumS. K. Md. Jasmine, Vidya Sagar Reddy G., Neelima Gorityala, Someswar Rao Sagurthi, Sandhya Mungapati, Kota Neela Manikanta, Uday Sankar Allam · pp. 135–147Same type: Article
• Article · VOLUME 13, ISSUE 2The Effects of Deoxyelephantopin on the Akt/mTOR/P70S6K Signaling Pathway in MCF-7 Breast Carcinoma Cells In VitroWan Failiza Wan Mohamad Fazil, Azimah Amanah, Muhammad Asyraf Abduraman, Shaida Fariza Sulaiman, Habibah Abdul Wahab, Mei Lan Tan · pp. 148–159Same type: Article
• Article · VOLUME 13, ISSUE 2Application of Physiologically Based Pharmacokinetic Modeling of Lamotrigine Using PK-Sim in Predicting the Impact of Drug Interactions and Dosage AdjustmentMohammed Farhan, Prathvi Rani, Fatimazahra Moledina, Thomas George, Hari Prabhath Tummala, Surulivelrajan Mallayasamy · pp. 160–166Same type: Article
• Article · VOLUME 13, ISSUE 2Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled TrialRajat Shah, Shefali Thanawala, Ramapalaniappan Abiraamasundari · pp. 167–174Same type: Article